Tumor marker response to <scp>SARS‐CoV</scp> ‐2 infection among patients with cancer-Reference-Cited by-同舟云学术

Tumor marker response to SARS‐CoV ‐2 infection among patients with cancer

Published:2022-03-15 Issue:14 Volume:11 Page:2865-2872
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Gunn Alexander H.¹^ORCID,Tashie Carolyn²,Wolf Steven³,Troy Jesse D.³,Zafar Yousuf¹²

Affiliation:

1. Duke University School of Medicine Durham North Carolina USA

2. Duke Cancer Institute Durham North Carolina USA

3. Department of Biostatistics and Bioinformatics Duke University Durham North Carolina USA

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4646

Reference36 articles.

1. Network NCC.Colon cancer (version 32021).2021. Accessed September 15 2021.https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf

2. Network NCC.Pancreatic adenocarcinoma (version: 2.2021). 2021. Accessed September 15 2021.https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf

3. Network NCC.Breast cancer (version 8.2021).2021. Accessed September 15 2021.https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf

4. Network NCC.Ovarian cancer/fallopian tube cancer/primary peritoneal cancer (version: 3.2021).2021. Accessed September 15 2021.https://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf

5. False-Positive Elevations of Carcinoembryonic Antigen in Patients With a History of Resected Colorectal Cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum hyaluronic acid and procollagen III, N-terminal propeptide levels are highly associated with disease severity and predict the progression of COVID-19;Frontiers in Cellular and Infection Microbiology;2023-10-04

2. Surveillance of gynecologic cancer patients post-COVID-19 vaccine: Are CA-125 levels reliable?;Gynecologic Oncology Reports;2023-02

3. The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity;Diagnostics;2022-11-29